Our nano tech healthcare platform delivers femtomolar molecular truth for multiple biomarkers through RNA, DNA and protein-based genome testing — powering Cardio Health, Proactive Beauty, Food & Environment screening from a single pocket-sized device.
Three world-class founders + one premier Indian institute = the only team built for large-scale hospital deployment, government POC programs, medical-device licensing and beauty-industry white-label partnerships.
Karolinska Institute / Oxford-trained genomics and AI specialist. Bridges cutting-edge molecular science with scalable AI-driven diagnostics architecture. Leads global partnerships and investor relations.
IIT Hyderabad nano-biosensor pioneer with 7 patents to his name. Architect of the fishing-hook detector platform. Leads all core R&D, IP strategy and TRL 7–8 scale-up roadmap.
Vodafone / Reliance scale-up and partnerships veteran. Drives commercial strategy, hospital chain rollouts, government tender programs and beauty-giant white-label deals across India and global markets.
Top new-generation IIT providing 13 PhD researchers embedded in our team, 2 platform patents secured, ICMR-CCMB regulatory validation and 15 years of R&D at 1/10th industry cost. Delivering peer-reviewed IP, government ties and unmatched scientific credibility.
Already ICMR-CCMB validated and clinically proven — ready for immediate hospital and government rollout.
The detector remains the same. Changing the "fishing hook" cartridge detects any new biomarker instantly — perfect for hospitals, governments and partners seeking future-proof diagnostics without re-engineering.
Same platform. Zero re-engineering. Four massive verticals addressable with a single swap of the fishing-hook cartridge.
Deploy X-Home™ in emergency, cardiology and pathology departments. Multiplex cardiac panel in <30 seconds. Zero capex reader model available. ICMR-CCMB validated for immediate rollout — pilot-ready for 6,000+ sites.
Request Hospital Demo →National POC programs for cardiac screening, infectious disease surveillance and rural health. Regulatory runway ready. 1-year 40°C shelf life for remote deployment. Low-cost, high-accuracy biomarker detection at population scale.
Discuss Government POC →License our nano-biosensor platform or integrate into your existing readers. 1,000× sensitivity upgrade instantly. Unlimited biomarker future-proofing. Turnkey partnership model — sign licensing MOU + joint validation today.
Explore Licensing MOU →White-label molecular skin biomarker testing for your consumer apps and retail lines. 18+ biomarkers. Predictive 2–5 year efficacy insights. Instant molecular proof for your claims — B2B licensing or B2C self-care device.
Start Beauty Partnership →While others offer surface imaging or bulky clinic machines, BioKubit delivers molecular truth in a pocket-sized platform.
| Platform | Molecular Depth | Sensitivity | Handheld POC | Predictive Insights | Biomarker Count |
|---|---|---|---|---|---|
| BioKubit X-Home™ | ✓ RNA/DNA/Protein | ✓ Femtomolar | ✓ <30 sec | ✓ 2–5 Year | ✓ 18+ Skin |
| Surface Imaging Devices | ✗ Surface Only | ✗ Low | ~ Bulky | ✗ No | ✗ Visual Only |
| Lab-Based Genomics | ✓ Molecular | ~ Moderate | ✗ Clinic Only | ~ Limited | ~ Few Panels |
| Consumer Skin Apps | ✗ Camera Only | ✗ None | ✓ Mobile | ✗ No | ✗ 0 |
| Platform | Sensitivity | Multiplex | Sample Volume | Shelf Life (40°C) | Biomarker Flexibility |
|---|---|---|---|---|---|
| BioKubit X-Home™ | ✓ 1,000× ELISA | ✓ Full Panel | ✓ <5 µL | ✓ 1 Year | ✓ Unlimited |
| Abbott-style POCT | ~ Standard | ~ Limited | ~ Moderate | ~ 6 Months | ✗ Fixed Panels |
| ELISA / Lab Benchtop | ~ Baseline | ~ Some | ✗ High Volume | ✗ Cold Chain | ✗ Slow Iteration |
| Lateral Flow / Rapid | ✗ Low | ✗ Single Only | ✓ Small | ✓ Good | ✗ One Biomarker |
"While others offer surface imaging or bulky clinic machines, BioKubit delivers molecular truth in a pocket-sized platform. The only solution ready for hospital chains, government programs, diagnostic leaders and beauty giants alike."
Impossible for fast-followers to replicate. ~$1M total cost. 15 years of R&D compressed into a deployable platform with regulatory validation and institutional backing.
Funds hospital/government pilots + beauty white-label deals. Partners commit $5–25M upfront licensing + royalties + co-branded consumer self-care upside. Clear path to $1B+ exit through beauty-tech acquisitions paid 9–14× revenue.
Reach out directly to our co-founders for hospital deployments, government POC discussions, licensing MOUs, beauty white-label partnerships or investor conversations.
IIT Hyderabad Incubated · ICMR-CCMB Validated · Robotic GMP Manufacturing Ready · Deploy for Hospitals, Diagnostic Chains & Personal Care Brands